Immunohistochemical Evaluation of DNA Methylation and Histone Modification in H. Pylori Associated Gastric Carcinoma

Assiut University

Status: Enrolling

Conditions: Gastric Carcinoma

Treatments: Diagnostic Test: Immunohistochemical staining for DNMT1 and EZH2

Study type: Observational

Funder types: Other

Identifiers

NCT05811546

Epigenetics Gastric Carcinoma

Details and patient eligibility

About

The goal of this cross-sectional study is to evaluate epigenetic modifications in gastric carcinogenesis, mainly in H. pylori gastritis vs gastric carcinoma. The main question[s] it aims to answer are:

• How does H. pylori infection cause gastric cancer?
• Can DNA methylation and other epigenetic changes predict and affect the development of gastric cancer? Formalin-fixed-paraffin-embedded tissue specimens will be obtained and reviewed for comparison between epigenetic changes in H. pylori gastritis and gastric adenocarcinoma.

Enrollment: 68 estimated patients

Sex: All

Ages: 30 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Resected specimens and endoscopic guided biopsies of intestinal type gastric carcinoma, H. Pylori associated gastritis, and non-H. Pylori gastritis with:
• Available full clinical data: (age, sex, complaint, findings in clinical examination).
• Full data of previous endoscopy and radiology.

Exclusion criteria

• Cases of diffuse type gastric carcinoma.
• Any case of gastric cancer, H. Pylori associated gastritis, non-H. Pylori gastritis, benign gastric lesions with missing clinical, endoscopic, radiologic or follow-up data.
• Cases with no available H&E stained slides or formalin fixed paraffin embedded block.

Trial design

68 participants in 3 patient groups

H. pylori Gastritis specimens

Treatment:

Diagnostic Test: Immunohistochemical staining for DNMT1 and EZH2

Non-H. pylori Gastritis specimens

Gastric carcinoma specimens